These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3991157)

  • 1. [Serum dopamine beta-hydroxylase activity in obesity and during a two-week fasting period].
    Halmy L; Nyakas C
    Orv Hetil; 1985 Mar; 126(11):627-33. PubMed ID: 3991157
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of weight loss on cortisol secretion in obese men with and without metabolic syndrome features.
    Parra MD; Martínez de Morentin BE; Alfredo Martínez J
    Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):28-34. PubMed ID: 16399489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fasting on plasma tryptophane and dopamine beta hydroxylase activity.
    Kuhn E; Rysánek K; Spánková H; Brodan V
    Act Nerv Super (Praha); 1978 Feb; 20(1):61-2. PubMed ID: 636780
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. III. Dopamine beta-hydroxylase (DBH) activity in the serum].
    Matsumoto H; Pacyna M; Pietruszewska I; Lewicka-Wysocka H
    Psychiatr Pol; 1983; 17(1):19-23. PubMed ID: 6622589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of dopamine beta-hydroxylase in the serum of patients with essential hypertension].
    Markiewicz M; Jach A; Horubała-Bielak G
    Pol Tyg Lek; 1978 Jul; 33(27):1057-9. PubMed ID: 693378
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of cold pressor test in man on serum immunoreactive dopamine-beta-hydroxylase and on dopamine-beta-hydroxylase activity.
    Freedman LS; Ebstein RP; Park DH; Levitz SM; Goldstein M; Davis S; Chu DS; Manger WM
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):873-8. PubMed ID: 4760894
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum dopamine-beta-hydroxylase activity in thyroid disorders.
    Nishizawa Y; Hamada N; Fujii S; Morii H; Okuda K
    J Clin Endocrinol Metab; 1974 Sep; 39(3):599-602. PubMed ID: 4415739
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum dopamine-beta-hydroxylase and the augmenting-reducing response.
    von Knorring L; Perris C; Ross SB
    Biol Psychiatry; 1980 Jun; 15(3):397-406. PubMed ID: 7378516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum dopamine-beta-hydroxylase activity in female manic-depressive patients.
    Rihmer Z; Bagdy G; Arató M
    Biol Psychiatry; 1984 Mar; 19(3):423-7. PubMed ID: 6722232
    [No Abstract]   [Full Text] [Related]  

  • 10. Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults.
    Harp JB; Henry SA; DiGirolamo M
    Obes Res; 2002 Oct; 10(10):985-90. PubMed ID: 12376578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women.
    Cornier MA; Donahoo WT; Pereira R; Gurevich I; Westergren R; Enerback S; Eckel PJ; Goalstone ML; Hill JO; Eckel RH; Draznin B
    Obes Res; 2005 Apr; 13(4):703-9. PubMed ID: 15897479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weight-reducing diet in the treatment of severe forms of obesity].
    Konev SF; Zykova TA
    Klin Med (Mosk); 1988 Aug; 66(8):120-2. PubMed ID: 3193724
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum dopamine beta-hydroxylase activity following subarachnoid hemorrhage in man.
    Harden TK; Klein RL; Smith RR; Thureson-Klein AK; Lowry MW
    Med Biol; 1975 Apr; 53(2):100-6. PubMed ID: 1152550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum dopamine-beta-hydroxylase activity in Down's syndrome: a familial study.
    Freedman LS; Goldstein M; Coleman M
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):543-9. PubMed ID: 4277650
    [No Abstract]   [Full Text] [Related]  

  • 15. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.
    Major GC; Doucet E; Jacqmain M; St-Onge M; Bouchard C; Tremblay A
    Br J Nutr; 2008 May; 99(5):1157-67. PubMed ID: 17977472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diet therapy in obesity].
    Nakamura T; Kawashima Y
    Nihon Rinsho; 1995 Jun; 53 Suppl():449-54. PubMed ID: 7563786
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the fasting therapy of obesity in childhood. I. The behavior of body weight in reduced calorie intake and absolute fasting].
    Spahn U; Plenert W; Pathenheimer F
    Z Kinderheilkd; 1967; 100(2):160-72. PubMed ID: 5591431
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of various hunger-cures on the behavior of body weight and blood pressure as well as on relevant blood parameters].
    Bartels RW; Bigalke C; Möllmann H; Schneeberger W; Wessels F
    Med Welt; 1974 Apr; 25(17):725-35. PubMed ID: 4421950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of fasting on phosphorus-calcium metabolism. Action of associated thyroid hormonotherapy].
    Asch L
    Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):41-5. PubMed ID: 4820525
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of obesity with a zero-calorie diet].
    Foldenauer A; Böhm P
    Munch Med Wochenschr; 1968 Oct; 110(41):2373-7. PubMed ID: 5761613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.